Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Back to Library
Vial

Peptide Library / Detail

Livagen

Short Peptide BioregulatorResearch use only

Half-life

Estimated 30-60 minutes (typical for short peptides)

Delivery

Subcutaneous or intramuscular injection

Dosage

Research Use Only

All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.

Purchase

No purchase links available

Description

Livagen is a synthetic tripeptide with the amino acid sequence Lys-Glu-Asp (KED). It is classified as a peptide bioregulator developed as part of research into short peptides that may influence gene expression and cellular function. Livagen has been primarily investigated for its potential effects on neuroendocrine and immune system regulation.

Usage

Research protocols typically involve subcutaneous or intramuscular administration at doses ranging from 10-20 mcg per day for cycles of 10-20 days. Some protocols suggest administration once daily, often in the evening. Cycles may be repeated with rest periods between courses.

Mechanism of Action

Livagen is believed to act as a peptide bioregulator that may interact with chromatin in cell nuclei to influence gene expression. It has been studied for potential effects on neuroimmune regulation, possibly modulating cytokine production and influencing the hypothalamic-pituitary axis. The exact molecular mechanisms remain under investigation.

Benefits(6)

  • May support cognitive function and mental clarity
  • Potential neuroendocrine system regulation
  • May influence immune system modulation
  • Possible support for stress response regulation
  • May contribute to overall homeostatic balance
  • Potential neuroprotective properties under investigation

Side Effects(5)

  • Limited safety data available from controlled studies
  • Potential injection site reactions (redness, swelling)
  • Unknown long-term effects
  • Possible allergic reactions in sensitive individuals
  • Interactions with other medications not well characterized

Livagen — frequently asked questions

  • What is Livagen?

    Livagen is a synthetic tripeptide with the amino acid sequence Lys-Glu-Asp (KED). It is classified as a peptide bioregulator developed as part of research into short peptides that may influence gene expression and cellular function. Livagen has been primarily investigated for its potential effects on neuroendocrine and immune system regulation.

  • What is the half-life of Livagen?

    Livagen has an approximate half-life of Estimated 30-60 minutes (typical for short peptides). The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.

  • How is Livagen administered?

    Livagen is typically delivered via subcutaneous or intramuscular injection. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.

  • How does Livagen work?

    Livagen is believed to act as a peptide bioregulator that may interact with chromatin in cell nuclei to influence gene expression. It has been studied for potential effects on neuroimmune regulation, possibly modulating cytokine production and influencing the hypothalamic-pituitary axis. The exact molecular mechanisms remain under investigation.

  • What are the researched benefits of Livagen?

    Studied benefits of Livagen include: May support cognitive function and mental clarity, Potential neuroendocrine system regulation, May influence immune system modulation, Possible support for stress response regulation, May contribute to overall homeostatic balance, Potential neuroprotective properties under investigation. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.

  • What are the side effects of Livagen?

    Reported side effects of Livagen include: Limited safety data available from controlled studies, Potential injection site reactions (redness, swelling), Unknown long-term effects, Possible allergic reactions in sensitive individuals, Interactions with other medications not well characterized. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.

Related peptides

Other cognitive compounds in the Peptides Calculator library.